Polarean Imaging Plc Cash Flow Conversion Efficiency

Latest as of June 2025: -0.473x

Polarean Imaging Plc cash flow conversion efficiency. Based on the latest financial reports, Polarean Imaging Plc (POLX) has a cash flow conversion efficiency ratio of -0.473x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-3.74 Million ≈ $-454.69 USD) by net assets (GBX7.90 Million ≈ $961.80 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Polarean Imaging Plc (2016–2024)

Cash flow conversion efficiency of Polarean Imaging Plc from 2016 to 2024. This chart illustrates how Polarean Imaging Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Polarean Imaging Plc for real-time trading data and today's change.

Polarean Imaging Plc Cash Flow Conversion Ratio Explained

Polarean Imaging Plc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Polarean Imaging Plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Polarean Imaging Plc ranked by their cash flow conversion efficiency. Also see market cap of Polarean Imaging Plc for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
PTT Global Chemical Public Company Limited
F:GCB
-0.057x
Red Rock Resources
LSE:RRR
-0.057x
Hana Microelectronics Public Company Limited
F:HAA1
0.055x
Plaza Centers NV
LSE:PLAZ
0.002x
Fantasy Network Ltd
TA:FNTS
-0.069x
Bluebird Merchant Ventures Ltd
LSE:BMV
0.000x
PTT Public Company Limited
F:PTOG
0.033x
Mingzhu Logistics Holdings Ltd
NASDAQ:YGMZ
0.030x

Annual Cash Flow Conversion Efficiency for Polarean Imaging Plc (2016–2024)

The table below shows the annual cash flow conversion efficiency of Polarean Imaging Plc from 2016 to 2024. Review POLX FCF to total liabilities ratio to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 GBX12.14 Million
≈ $1.48K
GBX-4.17 Million
≈ $-507.80
-0.344x +72.67%
2023-12-31 GBX8.30 Million
≈ $1.01K
GBX-10.43 Million
≈ $-1.27K
-1.257x -98.04%
2022-12-31 GBX19.30 Million
≈ $2.35K
GBX-12.26 Million
≈ $-1.49K
-0.635x -64.50%
2021-12-31 GBX31.74 Million
≈ $3.86K
GBX-12.25 Million
≈ $-1.49K
-0.386x +41.83%
2020-12-31 GBX8.73 Million
≈ $1.06K
GBX-5.79 Million
≈ $-705.05
-0.664x +33.29%
2019-12-31 GBX4.59 Million
≈ $558.48
GBX-4.57 Million
≈ $-555.51
-0.995x -65.73%
2018-12-31 GBX7.79 Million
≈ $947.99
GBX-4.68 Million
≈ $-568.98
-0.600x +21.06%
2017-12-31 GBX3.44 Million
≈ $418.60
GBX-2.62 Million
≈ $-318.25
-0.760x -158.60%
2016-12-31 GBX-585.75K
≈ $-71.27
GBX-759.99K
≈ $-92.47
1.297x --

About Polarean Imaging Plc

LSE:POLX UK Medical Devices
Market Cap
$11.75K
GBX96.56 Million GBX
Market Cap Rank
#31859 Global
#1291 in UK
Share Price
GBX0.08
Change (1 day)
-20.00%
52-Week Range
GBX0.08 - GBX0.22
All Time High
GBX106.50
About

Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent ind… Read more